Radiopharmaceuticals/Nuclear Medicine is a specialized field of medicine that covers all aspects of use of radioactive substances which are used for diagnosis or treatment of various diseases such as cancers, cardiovascular dise ....see more
The global nuclear medicine market, valued at US$4.9 billion in 2021, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$9.4 billion by the end of the period. The market growth in this sector is driven by factors such as advancements in radioisotope production technology and the rising prevalence of cancer and cardiovascular diseases (CVD).